Stimulation of duodenal bicarbonate secretion by carbenoxolone in rats: A comparative study with prostaglandin E2

General Pharmacology

Volumn 30, Issue 5, 1998, Pages 739-744

  Takeuchi, Koji ^a   Yagi, Koji ^a   Kitamura, Motohiro ^a   Kubomi, Masafumi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Carbenoxolone; Duodenal HCO3 secretion; Prostaglandins; Rat

Indexed keywords

BICARBONATE; CARBENOXOLONE; CYCLIC AMP; INDOMETACIN; ISOBUTYLMETHYLXANTHINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMMON BILE DUCT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG MECHANISM; DUODENUM SECRETION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ULCER AGENTS; BICARBONATES; CARBENOXOLONE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; HYDROGEN-ION CONCENTRATION; MALE; MEMBRANE POTENTIALS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031960836     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00339-X     Document Type: Article

References (32)

1. Bennett A., Melhuish P. B., Stamford F. I. Carbenoxolone and deglycyrrhized liquorice have little or no effect of prostanoid synthesis by rat gastric mucosa ex vivo. Br. J. Pharmac. 86:1985;693-695.
2. Bilski J., Konturek S. J. Role of nitric oxide in gastroduodenal alkaline secretion. J. Physiol. Pharmacol. 45:1994;541-553.
3. Cross S. and Rhodes J. (1972) Carbenoxolone: its protective action against bile damage to gastric mucosa in canine pouches (abstract). Gastroenterology 62, A-737.
4. Dembinska-Kiec A., Pallapies D., Simmet T., Peskar B. M., Peskar B. A. Effect of carbenoxolone on the biological activity of nitric oxide. relation to gastroprotection Br. J. Pharmac. 104:1991;811-816.
5. Derekanko M. J., Long J. F. Carbenoxolone sodium protects rat gastric mucosa against ethanol-induced necrosis. Proc. Soc. Exp. Biol. Med. 166:1981;394-397.
6. 3 transport. characteristics and proposed role in acidity regulation and mucosal protection Am. J. Physiol. 242:1982;G183-G193.
7. Garner A., Heylings J. R., Hampson S. E., Stanier A. M. Identification of agonists of duodenal alkaline secretion. J. Intern. Med. 228(Suppl):1990;97-193.
8. Goodier J. E. W., Horwich L., Galloway R. W. Morphological observation on gastric ulcers treated with carbenoxolone sodium. Gut. 8:1967;544-547.
9. 3 secretion. proposed mechanism and comparison with other secretagogues Gastroenterology. 111:1996;1558-1568.
10. Hallgren G., Flemstrom G., Sababi M., Nylander O. Effects of nitric oxide inhibition on duodenal function in rat. involvement of neural mechanisms Am. J. Physiol. 269:1995;G246-G254.
11. Henman F. D. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid. Gut. 11:1970;344-351.
12. Ivey K. J., Gray C. Effect of carbenoxolone on the gastric mucosal barrier in man after administration of taurocholic acid. Gastroenterology. 64:1973;1101-1105.
13. Khanm M. H. and Sullivan F. M. (1968) The pharmacology of carbenoxolone sodium. In Symposium on Carbenoxolone Sodium (Edited by Robson J. M. and Sullivan F. M.), pp. 5-14. Butterworths, London.
14. LaMont T., Ventola A. Stimulation of colonic glycoprotein synthesis by dibutyryl cyclic AMP and theophylline. Gastroenterology. 72:1997;82-86.
15. Lipkin M. Progress report. in "defense" of the gastric mucosa Gut. 12:1971;599-603.
16. Martin A., Gurrieri G., Sturniolo G. C., Naccarato R. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat. Samuelsson B., Paoletti R. W., Ramwell P. W. Advances in Prostaglandin, Thromboxane and Leukotriene Research Vol. 12. 1983;409-411 Raven Press, New York.
17. Okabe S., Takata Y., Takeuchi K., Takagi K. Effects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals. Am. J. Dig. Dis. 21:1976;618-625.
18. Peskar B. M., Holland A., Peskar B. A. Effect of carbenoxolone on prostaglandin synthesis and degradation. J. Pharm. Pharmac. 28:1976;146-148.
19. Rees W. D., Garner A., Heylings J. R., Flemstrom G. Effect of carbenoxoline on alkaline secretion by isolated amphibian gastric and duodenal mucosa. Eur. J. Clin. Invest. 11:1981;481-486.
20. Reimer R., Heim H. K., Muallem R., Odes H. S., Sewing K. F. Effects of EP-receptor subtype specific agonists and other prostanoids on adenylate cyclase activity of duodenal epithelial cells. Prostaglandins. 44:1992;485-493.
21. Simson J. N. L., Merhav A., Silen W. Alkaline secretion by amphibian duodenum II. short-circuit current and Na and Cl fluxes Am. J. Physiol. 240:1981;G472-G479. . a.
22. Simson J. N. L., Merhav A., Silen W. Alkaline secretion by amphibian duodenum III. effects of dbcAMP, theophylline, and prostaglandins Am. J. Physiol. 240:1981;G528-G534. . b.
23. Takeuchi K., Matsumoto J., Ueshima K., Okabe S. Role of capsaicin-sensitive afferent neurons in alkaline secretory response to luminal acid in the rat duodenum. Gastroenterology. 101:1991;954-961.
24. Takeuchi K., Furukawa O., Tanaka H., Okabe S. A new model of duodenal ulcers induced in rats by indomethacin plus histamine. Gastroenterology. 90:1986;636-645. . a.
25. Takeuchi K., Ueki S., Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig. Dis. Sci. 31:1986;1114-1122. . b.
26. Takeuchi K., Niida H., Ueshima K., Okabe S. Determination of gastroduodenal alkaline response in the rat. J. Pharmac. Methods. 24:1990;189-202. . a.
27. 2-receptors and Ca-dependent process J. Pharmac. Exp. Ther. 254:1990;465-470. . b.
28. 3 secretion in rats. J. Pharmac. Exp. Ther. 266:1993;1512-1519.
29. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase in rats. J. Gastroenterol. Hepatol. 9:1994;S50-S54.
30. Takeuchi K., Takehara K., Kato S., Yagi K. PACAPs stimulate duodenal bicarbonate secretion at PACAP receptors in the rat. Am. J. Physiol. 272:1997;G646-G653. . a.
31. Takeuchi K., Yagi K., Kato S., Kitamura M. Role of prostaglandin E receptor subtypes in gastroduodenal bicarbonate secretion in rats (abstract). Gastroenterology. 113:1997;1553-1559. . b.
32. Wotkinson G. Treating ulcer diseases with carbenoxolone sodium. Postgrad. Med. 44:1968;91-98.